BioClin has been acquired by Trimb Healthcare
Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.
Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.
Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.
Oaklins' team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.
Talk to the deal team
Casper Oude Essink
Associate Director
Amsterdam, NetherlandsOaklins Netherlands
Related deals
Zoofy has raised growth capital for its expansion into Germany
Zoofy, an Amsterdam-based platform connecting professional handymen with consumers and businesses, has raised growth capital from a private investor for its expansion into Germany. The company expects to launch its German platform in the second quarter of this year.
Learn moreAce Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Learn moreInside Pensions has been acquired by ZEDRA Group
The owners of Inside Pension Ltd. have sold the business to ZEDRA Group.
Learn more